A Follow-up Assessment of Resistance to ABT-333 in Hepatitis C Virus (HCV)-Infected Subjects Who Have Received ABT-333 in ABT-333 Studies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel E Cohen, MD
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 11141
Santurce, Puerto Rico
- Site Reference Id/investigator# 17665
Anaheim, California, United States
- Site Reference Id/investigator# 17367
Los Angeles, California, United States
- Site Reference Id/investigator# 17672
Los Angeles, California, United States
- Site Reference Id/investigator# 10381
Orlando, Florida, United States
- Site Reference Id/investigator# 17667
Baton Rouge, Louisiana, United States
- Site Reference Id/investigator# 14461
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2008
- Primary completion
- 31 May 2010
- Completion
- 31 May 2010
- Last update posted
- 8 Jan 2015
- Registered enrollment
- 35
- Registry id
- NCT00726882
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.